Endomorphin-1 and endomorphin-2 were recently postulated to be endogenous m
u-opioid receptor agonists. We have investigated the antinociceptive and an
tihyperalgesic effects of intrathecally administered endomorphins in cumula
tive doses (0.1-100 mu g) on acute and inflammatory pain sensations in awak
e rats. In the tail-flick test, both peptides caused a dose-dependent short
-lasting antinociception, except at the highest dose, which caused motor im
pairment also. The dose-response curves revealed the development of acute t
olerance (tachyphylaxis) to endomorphin. Similarly in the carrageenan-injec
ted paw, the endomorphins (10 mu g) exerted transient antinociceptive effec
ts. These are the first data to demonstrate decreased responsivity in model
s of both acute and inflammatory pain after intrathecal administration of e
ndomorphin-1 and -2 in awake rats.